SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Wilke AC, Doebele C, Zindel A, Lee KS, et al. Blood 2022;139:538-553.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wilke AC, Doebele C, Zindel A, Lee KS, et al. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood 2022;139:538-553.
PMID: 34624079